First-line and second-line antiretroviral therapy - Author's reply

被引：0
|
作者：
Carr, A [1 ]
机构：
[1] St Vincents Hosp, Sydney, NSW 2010, Australia
来源：
LANCET | 2004年 / 364卷 / 9431期
关键词：
D O I：
10.1016/S0140-6736(04)16718-4
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：330 / 330
页数：1
相关论文
共 50 条
  • [21] Changes of Eradication rates of first-line and second-line therapy for Helicoabacter pylori infection
    Kim, G.
    Kim, Y.
    Song, J.
    Park, S.
    HELICOBACTER, 2010, 15 (04) : 341 - 341
  • [22] CHANGES OF ERADICATION RATES OF FIRST-LINE AND SECOND-LINE THERAPY FOR HELICOABACTER PYLORI INFECTION
    Park, S.
    HELICOBACTER, 2015, 20 : 96 - 96
  • [23] Second-line failure and first experience with third-line antiretroviral therapy in Mumbai, India
    Khan, Samsuddin
    Das, Mrinalini
    Andries, Aristomo
    Deshpande, Alaka
    Mansoor, Homa
    Saranchuk, Peter
    Isaakidis, Petros
    GLOBAL HEALTH ACTION, 2014, 7 : 1 - 6
  • [24] First-line vs second-line antibiotics for treatment of sinusitis
    Anon, JB
    Jacobs, MR
    Poole, MD
    Singer, ME
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (11): : 1395 - 1395
  • [25] Antimuscarinics in the Treatment of OAB: Is there a First-Line and a Second-Line Choice?
    Apostolidis, Apostolos
    CURRENT DRUG TARGETS, 2015, 16 (11) : 1187 - 1197
  • [26] What is first-line and what is second-line therapy in adult patients with moderate to severe Crohn's disease?
    Panaccione, Remo
    JOURNAL OF THE CANADIAN ASSOCIATION OF GASTROENTEROLOGY, 2025, 8 : S1 - S5
  • [27] Emergent Resistance to Dolutegravir Among INSTI-Naive Patients on First-line or Second-line Antiretroviral Therapy: A Review of Published Cases
    Cevik, Muge
    Orkin, Chloe
    Sax, Paul E.
    OPEN FORUM INFECTIOUS DISEASES, 2020, 7 (06):
  • [28] Inflammatory biomarkers and soft tissue changes among patients commencing second-line antiretroviral therapy after first-line virological failure
    Mwasakifwa, Gwamaka Eliudi
    Amin, Janaki
    Kelleher, Anthony
    Boyd, Mark A.
    AIDS, 2021, 35 (14) : 2289 - 2298
  • [29] Virologic efficacy of tenofovir, lamivudine and dolutegravir as second-line antiretroviral therapy in adults failing a tenofovir-based first-line regimen
    Keene, Claire M.
    Griesel, Rulan
    Zhao, Ying
    Gcwabe, Zimasa
    Sayed, Kaneez
    Hill, Andrew
    Cassidy, Tali
    Ngwenya, Olina
    Jackson, Amanda
    van Zyl, Gert
    Schutz, Charlotte
    Goliath, Rene
    Flowers, Tracy
    Goemaere, Eric
    Wiesner, Lubbe
    Simmons, Bryony
    Maartens, Gary
    Meintjes, Graeme
    AIDS, 2021, 35 (09) : 1423 - 1432
  • [30] Failure of Vedolizumab as First-Line Biologic Does Not Decrease Response Rates of Second-Line Therapy
    Ritter, Timothy E.
    Fourment, Chris
    Okoro, Tracy C.
    Hardin, Thomas C.
    Van Anglen, Lucinda J.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S381 - S382
12345